T1	Participants 115 144	stem cell transplant patients
T2	Participants 287 350	117 patients who had undergone stem cell transplantation (SCT).
T3	Participants 720 755	subgroup of allogeneic SCT patients
T4	Participants 893 935	autologous SCT patients with breast cancer
T5	Participants 1203 1215	SCT patients
